Press Releases
Publication of Data on the Novel Antibiotic CRS0540
Announcement Regarding CRS0540: Crestone, Inc. and Praedicare Inc. Announce the Publication of...
Read More
Crestone, Inc. joins the Antimicrobials Working Group
June 8, 2021 – Announcement: Crestone, Inc. joins the Antimicrobials Working Group to Combat...
Read More
First Patient Enrolled in Phase 2 Clinical Trial + QIDP & Fast Track
June 7, 2021 – Announcement: Crestone, Inc. Enrolls First Patient in Phase 2 Clinical Trial...
Read More
Funding Secured for Development Through Phase 1: CRS0540
July 1, 2020 – Announcement: Crestone, Inc. Secures NIH Funding for Development Through...
Read More
Grant Received from State of Colorado Advanced Industries Accelerator
May 29, 2020 – Announcement: Crestone, Inc. receives $250,000 Grant from State of Colorado...
Read More
NIH Funding Secured for Preclinical Development of CRS3123
Apr 27, 2020 – Announcement: Crestone, Inc. Secures NIH Funding for Preclinical Development...
Read More
Funding: Preclinical Development of Novel Antibiotic for NTM Infection
CFF Funding Secured Crestone, Inc. (Boulder) Secures CFF Funding for Preclinical Development of...
Read More
NIH Funding Secured for Phase 2 Clinical Trial of CRS3123
Sep 12, 2019 – Announcement: Crestone, Inc. Secures NIH Funding for Phase 2 Clinical Trial...
Read More
Research Agreement with Colorado University at Boulder
Dec 20, 2017 – Announcement: Crestone enters a Research Agreement with Colorado University...
Read More
Other News
Presentation at ASM Microbe, Los Angeles, June 20, 2025: Microbiome Analysis of Fecal Samples Collected in a Phase 2 Clinical Trial Comparing CRS3123 Vs. Vancomycin to Treat C. difficile Infection
Crestone made an impact at the ASM Microbe 2025 conference in Los Angeles by presenting groundbreaking research on microbiome analysis.
Become a Part of Our Projects
Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investor or a team member.
Inquiries
Have a question or comment? Follow the link below to contact us about general inquiries.
Careers
Find work in a team-oriented environment at one of the leading Colorado pharma companies.
Investors
If you're interested in becoming an investor to help fund our research and development, contact us today.